Notify me when Ian Jacobs files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| Orielle Acquisition Corp. | Common Stock, par value $0.0001 per share | 5% | 250,000 | Ian Jacobs | 30 Sep 2025 | ||||
| Lomond Therapeutics Holdings, Inc. | Common Stock, par value $0.0001 per share | 0.59% | 175,000 | Ian Jacobs | 31 Dec 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|